Table 4.
Performance of the model in the global sample and in different geographic areas
Regions |
GOF test Ĥ | p | GOF test Ĉ | p | O/E ratio | 95% CI | aROC |
---|---|---|---|---|---|---|---|
Australasia | 15.25 | 0.12 | 8.09 | 0.62 | 0.92 | 0.85–0.99 | 0.839 |
Central, South America | 78.01 | <0.01 | 80.82 | <0.01 | 1.30 | 1.23–1.37 | 0.855 |
Central, Western Europe | 56.45 | <0.01 | 47.89 | <0.01 | 0.84 | 0.79–0.90 | 0.861 |
Eastern Europe | 19.45 | 0.03 | 18.69 | 0.04 | 1.09 | 1.00–1.19 | 0.903 |
North Europe | 2.44 | 0.99 | 2.34 | 0.99 | 0.96 | 0.83–1.09 | 0.814 |
Southern Europe, Mediterranean countries | 14.18 | 0.16 | 20.78 | 0.02 | 1.02 | 0.98–1.05 | 0.834 |
North America | 10.57 | 0.39 | 9.63 | 0.47 | 0.91 | 0.78–1.04 | 0.812 |
Global database | 10.56 | 0.39 | 14.29 | 0.16 | 1 | 0.98–1.02 | 0.848 |
GOF: Hosmer-Lemeshow goodness-of-fit; O/E: observed-to-expected mortality; CI: 95% confidence interval; aROC: area under the receiver operating characteristic (curve).